chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I  was 4 weeks pregnant at the time of my second dose. I miscarried at around 7weeks 6 days. It was suggested due to potential Triploidy but I thought it would be informative that you know.
Severe Nausea; severe headache; vomited once; slight dizziness; Dose 1 given on 18Dec2020 and Dose 2 on 15Jan2021 (Day 29); Dose 1 given on 18Dec2020 and Dose 2 on 15Jan2021 (Day 29); This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248), intramuscular on 15Jan2021 06:30 at a single dose on right arm for COVID-19 immunization. Medical history included fistula repair resulting into placement of neurostimulator. The patient was not pregnant at the time of vaccination. No known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included ibuprofen (IBUPROFEN), biotin (BIOTIN) and Nature's Made multivitamins. The patient previously received first dose of BNT162B2 on 18Dec2020 for COVID-19 immunization (lot number: EK5730, administration time: 06:30 AM, route: Intramuscular, vaccine location: Right arm, dose number: 1). No other vaccines received 4 weeks prior to vaccination. On 16Jan2021 09:00, the patient experienced severe nausea, severe headache, vomiting once and slight dizziness. No treatment was given for the adverse events. The patient has not been tested for COVID post vaccination. The patient recovered from severe nausea, severe headache, vomiting once and slight dizziness on Jan2021.
Redness appeared on left arm around injection site on the 8th day post vaccination. Online references described as "Covid Arm".  As of 9th day post vaccine, no related pain or itching.
This spontaneous report as received from a physician and an office manager at the physician's office via a company representative refers to a 36 year old male patient. "Around 3 days ago", on approximately 13-MAY-2013 the patient was vaccinated with hepatitis b vaccine (manufacturer unknown) (lot # reported as 9722404, expiry date 16-JUN-2012) (strength and total daily dose not reported). It was reported that the adult dose of hepatitis b vaccine (manufacturer unknown) the patient received was expired. The physician was unsure of the brand name and manufacturer of the hepatitis B vaccine. The patient was not experiencing any known symptoms. No adverse effect was reported. It was unspecified whether the patient sought for medical attention. The outcome was unknown. It was also reported that the patient received a dose of VAQTA instead of a dose of adult VAQTA on 13-MAY-2013 (Related ID: 1305USA012913).
I tested positive for Covid-19 on December 25, 2022. I experienced weakness, tiredness, fever of 99.0 chills, sneezing, coughing, headaches. No medications were taken.
Severe swelling of affected arm, joint and muscle pain and swelling. Given NSAID therapy with good relief. Questionable serum sickness versus allergy to serum. Phone consult.
Slight headache every day; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a 67-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th November 2020, the patient received Shingrix. In November 2020, less than a week after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was recovering/resolving.   It was unknown if the reporter considered the headache to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported, but it could be 66 or 67 year The patient receiced Shingles vaccination and had a slight headache every day.  The patient taking Over-the-counter medication and amp getting some relief, was this reaction common.
This spontaneous report was received from a pharmacist refers to a 75 year old female patient. Patient's pertinent medical history and drug reactions/allergies were not reported. On 07-JUN-2015 the patient was vaccinated with ZOSTAVAX (lot # K018173, expiry date:10-JAN-2016) dose 1 (reported as single dose), subcutaneous in the right arm. Concomitant medications were unspecified. Patient reported that she experienced tingling of her lips (paresthesia oral) and mild trouble while swallowing 30 minutes after administration of ZOSTAVAX vaccine on 07-JUN-2015. On an unspecified date in June 2015, patient developed redness and a rash around the injection site of the right arm. Patient sought medical attention and went to the pharmacy on 09-JUN-2015. No lab diagnostic studies were performed. No treatment was provided for the adverse events. Outcome of the events were reported as not recovered. Causal relationship of the events with respect to therapy with ZOSTAVAX was not reported. Additional information has been requested.
Child was at school. Mother reports child broke out in hives especially on trunk and also had hives in groin areas and a few on arms and face. He had diarrhea several times. Mother took child to doctor and he gave him a steroid shot and sent him home on Benadryl and prednisone. Reports improved within 15 minutes after injection. Pt had a reaction at his Hep-B #2. He is to receive no more Hep-B vaccinations per his PMD.
I developed a UTI a urinary tract infection; my pelvic floor is weakening; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1, I ended up catching COVID on Aug 30th even though I was fully vaccinated), for COVID-19 immunization, reaction(s): "COVID", "ended up catching COVID".  The following information was reported: PELVIC FLOOR MUSCLE WEAKNESS (non-serious) with onset 2021, outcome "unknown", described as "my pelvic floor is weakening"; URINARY TRACT INFECTION (non-serious) with onset 11Nov2021, outcome "unknown", described as "I developed a UTI a urinary tract infection". Therapeutic measures were taken as a result of pelvic floor muscle weakness.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient came in for a travel consultation.  In her prepared folder, her vaccine record had been printed out by a co-worker, which showed no record of the 3 above shots.  After administration of said vaccines, this nurse went to place in the patient's immunization record and found that the patient had 2 records, one with her correct name, and one with her names transposed.  Her correct record showed that she had already received the 3 shots.  I let the patient and her daughter know what happened, no adverse events were noted.
It started out as very bad shoulder pain with a bit of swelling, but shortly after I could feel a tightness when my arm was held all the way outward. The next morning, the top of my ring finger felt numb and as the days progressed it moved to the whole finger and the finger tip of my middle finger as well. I have not regained any of feeling that I lost
Fever lasted 2 days,  headache lasted 3+ days, chills lasted 2 days, body aches lasted almost 2 days, sore arm lasted  2-3 days.  Took 500mg Acetaminophen one time about 23 hours after symptoms began.
Erythema, warmth, swelling. Diphenhydramine 25 mg once, Clindamycin 300 mg tid.
Sore left arm/shoulder and neck, Fever,  head sweating, post nasal drip, Cough, diarrhea, dizziness, weakness
Patient did not experience an adverse event. The vaccine vial had previously thawed and been refrozen four months prior, and was inadvertantly used for the immunization.
Violent throwing up, dry heaves unable to get up and walk weakness, extreme muscle aches and  sharp stabbing jolts of pain
We gave her the flu vaccine at 9:10am then about 10 minutes later she was having nausea and dizziness. She said she hadn't eaten anything before showing up for her shot. We got her a Sprite and sat next to her for the next 20 minutes. She started experiencing chest pain then EMS was called and took her away about 9:30.
past medical history of asthma, HTN, mood disorder, CHF, valvular disease who is presenting for evaluation of shortness of breath.  Patient states that she has been having worsening shortness of breath over the last several days, then today when she woke up she felt like she could not take a breath and therefore emergency was called.  She states that over last month she has been out of her inhalers, in addition she reports about the 1 week of rhinorrhea, productive cough, in addition the whole family has been sick with respiratory symptoms for last 2 to 3 days, her daughter tested positive for Covid couple days ago.   Per EMS, arrival patient hypoxic to 80s, given epinephrine, magnesium, DuoNeb's, placed on BiPAP in route.  On arrival to the emergency department she was able to transition to nasal cannula, given Solu-Medrol, continued on inhalers however had a worsening shortness of breath and work of breathing therefore placed on BiPAP with improvement of symptoms.  Further work-up shows mild increase lactate, mild increase in CRP, no leukocytosis, Covid later returns positive.   She continues to smoke.  Acute hypoxic respiratory failure; Asthma/COPD exacerbation Vaccinated w/ J&J, sx onset ~ 12/25, pos 01/01, admitted 01/01, initial O2 4-5L, BiPAP for WOB. CXR showing mild r mid lung and basilar atelectasis. Ddimer 1.7 on admit, CT PE Neg, D-dimer later normalized. Started on IV Steroids and O2 weaned down to 1L at rest and 4L with activity. Exacerbation also 2/2 above and in context of out of her inhalers for a month. Reordered Neb tx, Albuterol inhaler for discharge, and Dexamethasone 6mg x6 more days to complete 10d steroid treatment.. Complete 5d doxy after discharge. Encouraged pulmonary toilet as above. Encourage outpatient PFTs.  - Cont scheduled albuterol, Mucinex for 2-3 days - Home O2, wean as able, PCP f/u - Encouraged Tobacco cessation, aggressive pulmonary toilet at home w/ Aerobika, IS, prn antitussives - f/u PCP re: COVID Vaccine Booster around 4/1/22   Chest Pressure, resolved: States since 1/4 pm,  her mucus is thicker and she is having some constant chest pressure, worse with coughing and positional changes. Denies associated ACS sxs. EKG repeat stable. Trops 18 -- >18, stable. Most likely related to pulm condition above, asxs by afternoon.    CHF H/o valvular heart disease: moderate MS, moderate MR HTN PTA amlodipine, lisinopril; per EMR hospitalization in 3/2021 for CHF exacerbation w/ lasix gtt; d/c-ed on Bumex 2mg BID though it doesn't seem she still takes it, no recent follow-up, last had 30d fill in April. BNP on admission wnl is reassuring as it essentially rules out acute CHF exacerbation. No crackles on exam, appears euvolemic. Advised close f/u outpatient cardiology team, euvolemic this admission did not restart diuretic.   Tobacco Use: Counseled on Cessation, encouraged OTC nicotine replacement.    Mood disorder:  cont PTA Effexor and Cymbalta   DM2:  Cont PTA ozempic, A1c updated 1/1 and 6.0.
Vaccine that had been more than 30 days in the refrigerator was given to 16 patients/vaccinate past its expiration date of 10/1/21; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that had been more than 30 days in the refrigerator was given to 16 patients/vaccinate past its expiration date of 10/1/21) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that had been more than 30 days in the refrigerator was given to 16 patients/vaccinate past its expiration date of 10/1/21). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that had been more than 30 days in the refrigerator was given to 16 patients/vaccinate past its expiration date of 10/1/21) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was reported  No treatment medication information was reported   This case was linked to MOD-2021-352611 (Patient Link).
Cellulitis 6x7 area of erythema on the left outer arm--tender with edema.  Area is hot.
pt devel blistering rash over last few days-about 12 lesions;seen in office & dx of varicella;
This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of Vaccine Products) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect products included non-company products COVID-19 VACCINE NRVV AD26 (JNJ 78436735) for COVID-19 vaccination and ADALIMUMAB (HUMIRA) for Rheumatoid arthritis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form, first dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) CF, Solution for injection in Prefilled pen. In May 2022, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of Vaccine Products). In June 2022, COVID-19 (COVID-19) had resolved. At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Interchange of Vaccine Products) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2022, SARS-CoV-2 test: positive POSITIVE. In June 2022, SARS-CoV-2 test: negative Negative. No Concomitant and Treatment medications details were not reported. Company Comment: This spontaneous case concerns a 59-year-old, male patient with no relevant medical history who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with a positive SARS-CoV-2 test), which occurred on unspecified interval after receiving the booster dose of mRNA-1273 vaccine. Interchange of vaccine products is noted in the case as patient received COVID-19 VACCINE NRVV AD26 (JNJ 78436735) as primary series of COVID-19 vaccination. Patient has recovered and tested negative for COVID-19 test a month after the event onset. The benefit-risk relationship of mRNA-1273 is not affected by this report. Sender's Comments: This spontaneous case concerns a 59-year-old, male patient with no relevant medical history who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with a positive SARS-CoV-2 test), which occurred on unspecified interval after receiving the booster dose of mRNA-1273 vaccine. Interchange of vaccine products is noted in the case as patient received COVID-19 VACCINE NRVV AD26 (JNJ 78436735) as primary series of COVID-19 vaccination. Patient has recovered and tested negative for COVID-19 test a month after the event onset. The benefit-risk relationship of mRNA-1273 is not affected by this report.
fever to 102, abd cramps;swollen lymph nodes, dizziness, fever to 104 hosp x 2 days;improving;
Severe headache onset at 4pm only normal headache at this time, woke me up at 12:30am was severe. Took 2 regular Tylenol eased up after 30 minutes. slight headache lingering on day 3.
Loose BM, felt funny in the head.  Reports "white coat syndrome" BP 154/93, HR 80.  Observed for 50 minutes.  Reported that symptoms had resolved. BP 137/87, HR 78.
This spontaneous report was received from a licensed practical nurse and refers to multiple unspecified patients of unknown age and gender. Patients' pertinent medical history and drug reactions or allergies were not reported. On unknown dates, patients were vaccinated with improperly stored doses (temperature excursion) of GARDASIL (lot number L040459 and expiration date 06-APR-2017, dose and route of administration were not reported). Concomitant therapy was not reported. No adverse effects were reported. There was no previous temperature excursion and it was not a data logger. No product quality complaint was involved. This is one of the two reports received from the same reporter. Additional information has been requested.
After the first shot (02/11/2021) I had a Gout inflammation like no other; it was swelling and very painful I couldn't walk;  this time I had it on the left foot which was rarely the case;I had the chills; headache and runny nose; this all lasted two days; After my 2nd round of shots (03/09/21): same thing happened, my Gout was so bad and I couldn't walk; again I was off work for two days; then on 03/28/21, I had yet another bout of glout inflammation....extremely bad, I was off my foot for 5 days; I finally called the doctor on the 31st of March and the 1st of April;  this time my foot was swollen, I couldn't even wear slippers &/or shoes.  all in all, between the two shots, I had three gout flare-ups which normally would be in a year or two.
Severe BPPV  Treated by Semont Liberatory Maneuver X 2 Still symptomatic
groin rash 4 hours after vaccine - resolved 24 hours, took 2 doses of diphenhydramine,  scattered hives still present  early day 2,  severe upper back pain 24 hours after vaccine resolved within 3 hours with acetaminophen/heating pad
Dizzy; Fatigue; Diarrhea; This case was reported by a consumer and described the occurrence of dizziness in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included adalimumab (Humira) solution for injection in pre-filled pen for crohn's disease.   On an unknown date, the patient received Shingrix and Humira (subcutaneous) at an unknown dose and frequency. On an unknown date, unknown after receiving Shingrix, the patient experienced dizziness, fatigue and diarrhea. Humira was continued with no change. On an unknown date, the outcome of the dizziness, fatigue and diarrhea were unknown.   It was unknown if the reporter considered the dizziness, fatigue and diarrhea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After receiving Shingrix and Humira, the patient experienced dizziness, fatigue and diarrhea. The reporter considered the dizziness, fatigue and diarrhea to be reasonable possibile to Shingrix.
Child's arm swollen twice size on (L) (25.5cm) than (R) (21cm) erythema patches underside (L) arm from armpit to mid arm. Pain, myalgia, warmth, no redness at injection site.
Patient felt severe pains in the joints of her hips, knee, and shoulders. Also, she was in a state of confusion where she couldn't remember simple things, people, or numbers.
I received my 2nd Moderna COVID 19 vaccination EUA on 02/01/2021 around noon (12:00 pm).   I did have a large lose stool around 7:00 pm and felt gassy.  I began having a back ache and low grade fever around 8:30 pm, so I went to bed.  I woke up around 1:00 am on 2/2/21 and had a fever of 101.0 degrees.  I woke up again at 2:30 am and my fever was 103.4 degrees.  I was shivering uncontrollably (teeth chattering), body aches and could not warm up.  I called in sick to work on 2/2/21 and felt nauseated and dizzy if I got up to go to the bathroom.  I took Tylenol, but my fever was between 100.8 and 101 degrees throughout the day despite Tylenol.  After taking Tylenol at 6:00 pm on 2/2/21, I took my temperature at 8:00 pm which was 100.8 degrees and went to bed.  I could only eat saltine crackers and half a bowl of soup when my fever was lower and I could get out of bed the entire day on 2/2/21, as well as sip on water throughout the day when I wasn't sleeping.  I woke up this morning on 2/3/21 wet as my fever broke.  I felt better as far as no fever and body aches, but still feel weak today as I haven't had much to eat.  I had a small amount of yellowish loose stool this morning and lethargic but no fever.
Breakthrough case admission after 4 vaccines Moderrna 3/13/21 Lot# 001B21A;  Moderna 4/0/21 Lot# 016B21A;  Moderna 11/11/21 Lot# 004F21A;  Moderna 8/26/22 Lot# 052B22A
PATIENT RECEIVED 1 DOSE OF MODERNA ON 08/18/2021 AND RECIEVED ANOTHER DOSE OF JANSSEN ON 09/10/2021
Lymphadenopathy-L neck swelled up and lymph nodes palpable just above the collarbone on the side of neck. Injection was given in  the left arm.
Reported shortness of breath lasting few minutes and spontaneously resolving, fatigue, and headache.
Patient experienced slight fever 99.5 and vomiting on Saturday - 1/9/2021.  Symptoms resolved by 1/10/2021.
This spontaneous report as received from a health care worker refers to unspecified number of patients of unknown age and unknown gender. The patient's pertinent medical history was not reported. On an unknown date, the unspecified number of patients were vaccinated with improperly stored VARIVAX (Merck). No adverse effects were reported. No product quality complaint (PQC) was reported VARIVAX (Merck). This case is linked to case # 1412USA004781 (same reporter link). Additional information has been requested.
Received phone call on 02/18/2010 from mother to report son had a temperature of 103 degrees and general body aching. He had his first MMR and second Hepatitis A ten days ago. No rash or swollen glands reported.  Nurse called client on 02/22/2010. Mom reports fever lasted for 2 days. He now has upper respiratory symptoms: cough, sore throat, chest pain with coughing. He plans to see MD if symptoms do not resolve or get worse in next couple of days.
inadvertent administration is reported in an pt who recvd .5cc of fluogen lot# 01872P, exp 30JUN93; pt recvd expired flu vax OCT93; pt did not exp sorness or other apparent sx;
1/5/2021 Woke up with chills, body aches, fatigue, headache, GI cramping/upset, severe headache, pain at injection site that moved through neck/shoulder.  Later in the day, began breaking out into sweats, headache worsened, very fatigued.  Symptoms lasted over 48 hours.  Had taken tylenol and slept and drank fluids throughout this time to help.  1/7/2021 Woke up feeling much better.  Only symptom is pain at injection site.  Called professional ouchline through employer to update due to missing 2 days of work on 1/6/2021 and 1/7/2021.
This spontaneous report as received from a health care worker refers to a patient of unknown age. On 09-APR-2013, the patient was vaccinated with an expired dose of GARDASIL (Lot # 665607/1333Y, expiration date 25-JUN-2012) (route not reported). No adverse effect was reported. Additional information has been requested.